Research map: Early Serum Free Light Chain Response in Newly Diagnosed Multiple Myeloma: Documented Earlier Than MRD and Complementary in Prognosis

Back to the article

Papers in this map

  1. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group · Antonio Pierangelo Palumbo · 2015 · 2251 citations · Cited by this paper
  2. Low‐Dose Chidamide Maintenance Therapy After Hematopoietic Stem Cell Transplantation for T‐Cell Acute Lymphoblastic Leukemia: A Case Series · 2026 · Related
  3. Diagnosis and Management of Multiple Myeloma · Andrew J. Cowan · 2022 · 1038 citations · Cited by this paper
  4. Decoding the Heterogeneity of Diffuse Large B‐Cell Lymphomas: A Comprehensive Genetic, Transcriptomic, and Phenotypic Profiling of B‐Cell Lymphoma Cell Lines · 2026 · Related
  5. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† · Meletios Athanasios Dimopoulos · 2021 · 849 citations · Cited by this paper
  6. Sequential BV‐AVD Therapy in Richter Transformation: Insights Into the Management of Elderly Patients · 2026 · Related
  7. Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and management · S. Vincent Rajkumar · 2024 · 496 citations · Cited by this paper
  8. Nucleoporin 98 Rearrangements in Acute Leukemia: A Genomic Landscape Study · 2026 · Related
  9. A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma · Nikhil C. Munshi · 2020 · 438 citations · Cited by this paper
  10. Trends in Incidence and Survival of Patients With Primary Effusion Lymphoma in the United States: A Population Based Cohort Study · 2026 · Related
  11. Immortal Time Bias in Observational Studies · Kabir Yadav · 2021 · 438 citations · Cited by this paper
  12. Real‐World Treatment Patterns and Healthcare Resource Utilization of Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma in the United States · 2026 · Related
  13. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project · Mattia D’Agostino · 2022 · 434 citations · Cited by this paper
  14. Integrative Transcriptomic and Functional Analysis of PKMYT1 Reveals a Potential Therapeutic Target in Chronic Lymphocytic Leukemia · 2026 · Related
  15. Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data · Camille Maringe · 2020 · 208 citations · Cited by this paper
  16. Matching‐Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second‐Line Myelofibrosis Therapy · 2026 · Related
  17. Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system · Christine L.H. Snozek · 2008 · 169 citations · Cited by this paper
  18. Clinical Significance of FLT3‐ITD Variation Allele Frequency in Acute Myeloid Leukemia: A Multicenter Study · 2026 · Related
  19. EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma · Ola Landgren · 2024 · 129 citations · Cited by this paper
  20. Sustained Complete Response in Refractory Idiopathic Multicentric Castleman Disease Following a Single CD19 CAR T‐Cell Infusion: A Case Report With Mechanistic Insight · 2026 · Related
  21. The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045 · Allini Mafra da Costa · 2024 · 90 citations · Cited by this paper
  22. Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma · Kanichi Iwama · 2012 · 40 citations · Cited by this paper
  23. The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements · María‐Teresa Cedena · 2020 · 26 citations · Cited by this paper
  24. Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial · Eva-Maria Klein · 2021 · 9 citations · Cited by this paper
  25. Role of serum‐free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma · Paola Tacchetti · 2022 · 8 citations · Cited by this paper
  26. Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States · Jingyu Xu · 2025 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)